SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-751759
Filing Date
2016-10-28
Accepted
2016-10-28 16:53:02
Documents
1
Group Members
ARTHUR G. EPKER, IIIPAR CAPITAL MANAGEMENT, INC.PAR GROUP, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d279206dsc13da.htm SC 13D/A 85350
  Complete submission text file 0001193125-16-751759.txt   87324
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Subject) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-39998 | Film No.: 161959243
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE INTERNATIONAL PLACE, SUITE 2400 BOSTON MA 02110
Business Address C/O PAR CAPITAL MGT ONE INTERNATIONAL PLACE, SUITE 2401 BOSTON MA 02110 6175268964
PAR INVESTMENT PARTNERS LP (Filed by) CIK: 0001066867 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A